CALCIPOTRIENE

Post-LOE

Hikma

ANDATOPICALSOLUTION

Approved

Nov 2009

Lifecycle

Post-LOE

Competitive Pressure

30/100

Clinical Trials

Data completeness

4/8 — Partial

CALCIPOTRIENE by Hikma is attero™ topical suspension combines the pharmacological effects of calcipotriene as a synthetic vitamin d 3 analog and betamethasone dipropionate as a synthetic corticosteroid. First approved in 2009.

Drug data last refreshed 10h ago

$0.0BPart D

Mechanism of Action

ATTERO™ Topical Suspension combines the pharmacological effects of calcipotriene as a synthetic vitamin D 3 analog and betamethasone dipropionate as a synthetic corticosteroid. However, while their pharmacologic and clinical effects are known, the exact mechanisms of their actions in the treatment…

Indications

Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.

Clinical Trials (8)

NCT05811234N/ACompleted

A Study to Assess Treatment Satisfaction, Patient-reported Outcomes, Effectiveness, and Safety of a Fixed-dose Combination of Calcipotriene/Betamethasone Dipropionate PAD Cream in the Treatment of Mild-to-moderate Plaque Psoriasis of the Scalp in Adults

Started Jun 2023

291 enrolled

Plaque Psoriasis

NCT03122353Phase 1Completed

BE Study of Calcipotriene Hydrate and Betamethasone Dipropionate Topical Suspension in the Treatment of Scalp Psoriasis

Started Apr 2017

699 enrolled

Scalp Psoriasis

NCT01982552N/ACompleted

An Observational Study to Assess Patient Satisfaction and Control of Psoriasis With Calcipotriene/Betamethasone Dipropionate (Taclonex®) Topical Suspension, and Effect on Quality of Life

Started Jul 2013

147 enrolled

Psoriasis Vulgaris

NCT01582932Phase 1Completed

Evaluate Safety and Tolerability of Calcipotriene Foam 0.005% in Pediatric Subjects With Mild/Moderate Plaque Psoriasis

Started Apr 2013

36 enrolled

Psoriasis

NCT01563068Phase 1Completed

Safety, Tolerability, PD & PK of Calcipotriene 0.005% Foam, Under Maximal Use in 12-16 Year Olds With Plaque Psoriasis

Started Apr 2012

18 enrolled

Psoriasis

Worked on CALCIPOTRIENE at Hikma? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.